Analyst Price Targets — CCAP
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CCAP

Crescent Capital BDC is rated HOLD, with the stock trading at a record 0.600x NAV and an attractive 12.7% yield. The dividend was reset 19% lower to $0.34, now conservatively covered by NII at 1.06x, and management permanently cut fees. Portfolio credit quality remains pressured: NAV has declined for eight straight quarters, non-accruals are 4.8%, and the watch list is 14.7%.

LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP (“Crescent”), one of the leading alternative credit investment firms, announced today the final close of its second captive collateralized loan obligation (CLO) equity fund, Crescent CLO Equity Funding II, with $232 million in commitments. The fund doubled the size of its predecessor, Crescent CLO Equity Funding I, which closed in 2018 with $103 million in…

CCAP cut its dividend by 19% a few months ago. But I expect another dividend cut, as I see several signals of struggling NII. NII dropped nearly 22% year-over-year to $0.36 per share, leaving only a 6% margin of safety over the current base dividend and heightening payout risk.

Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript

Crescent Capital BDC NASDAQ: CCAP reported second-quarter net investment income of $0.36 per share, exceeding its $0.34 per-share base dividend but declining from $0.38 per share in the prior quarter excluding a one-time incentive-fee waiver.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CCAP.
U.S. House Trading
No House trades found for CCAP.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
